My thoughts for today FSD Pharma Recruitment has started for phase 2 trials MCAS
for their lead molecule FSD PEA , mast cells inflammatory idiopathic pain condition
lucid MS - which is their lead molecule for multiple sclerosis - The company has submitted an IND for phase 1 clinical trial with humans to the FDA awaiting news results from that to see when they will start phase 1
Australia has been open with psychedelics recently. A subsidiary was created by FSD Pharma - maybe something revolving around lucid pysch.
The end result will be dependent on hardline top line data from the clinical trials, no amount of pumping or bashing matters.
have a wonderful day I have to go cook dinner for the kids